Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

NCT01748500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Pantoprazole

Sponsor

University Health Network, Toronto